KURA ONCOLOGY INC. - COMMON STOCK

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

13 يناير 2025 09:46:04 بحسب NetDania Notify

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

10 يناير 2025 09:45:05 بحسب NetDania Notify

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

08 يناير 2025 09:45:16 بحسب NetDania Notify

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

07 يناير 2025 09:45:07 بحسب NetDania Notify

Kura Oncology Announces Senior Executive Promotions

06 يناير 2025 16:30:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

30 ديسمبر 2024 09:45:21 بحسب NetDania Notify

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

27 ديسمبر 2024 10:30:03 بحسب NetDania Notify

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

24 ديسمبر 2024 10:21:06 بحسب NetDania Notify

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

23 ديسمبر 2024 10:05:39 بحسب NetDania Notify

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

19 ديسمبر 2024 09:53:07 بحسب NetDania Notify

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

18 ديسمبر 2024 14:24:10 بحسب NetDania Notify

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

13 ديسمبر 2024 09:45:27 بحسب NetDania Notify

NetDania - New 12 months Low: KURA ONCOLOGY INC. - COMMON STOCK

12 ديسمبر 2024 13:14:10 بحسب NetDania Notify

Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting

09 ديسمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Kura Oncology to Host Virtual Investor Event on December 9, 2024

02 ديسمبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Kura Oncology to Participate in JMP Securities Hematology and Oncology Summit

25 نوفمبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias

20 نوفمبر 2024 17:00:00 بحسب Nasdaq GlobeNewswire

Kura Oncology Reports Third Quarter 2024 Financial Results

07 نوفمبر 2024 16:05:01 بحسب Nasdaq GlobeNewswire

Kura Oncology to Present Updated Data from KOMET-007 Combination Trial of Ziftomenib at ASH Annual Meeting

05 نوفمبر 2024 09:09:54 بحسب Nasdaq GlobeNewswire

Kura Oncology to Report Third Quarter 2024 Financial Results

31 أكتوبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire